Taffe B G, Zweier J L, Pannell L K, Kensler T W
Department of Environmental Health Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21205.
Carcinogenesis. 1989 Jul;10(7):1261-8. doi: 10.1093/carcin/10.7.1261.
BHTOOH (2,6-di-tert-butyl-4-hydroperoxyl-4-methyl-2,5-cyclohexadienone), a metabolite of the food antioxidant BHT (2,6-di-tert-butyl-4-methylphenol), has previously been shown to function as a tumor promoter in mouse skin. The metabolism of BHTOOH was examined to assess the role of reactive intermediates in mediating tumor promotion in this tissue. Free radical metabolites of BHTOOH were characterized in either isolated neonatal mouse keratinocytes or a cell-free hematin system using electron paramagnetic resonance (EPR) spectroscopy while non-radical, EPR silent products were characterized using HPLC separation coupled with UV or mass spectral detection. Incubation of BHTOOH with keratinocytes or hematin resulted in the generation of the BHT-phenoxyl radical detectable by EPR spectroscopy. Formation of the BHT-phenoxyl radical was prevented by heat inactivation of the cells prior to exposure to BHTOOH. Only one non-radical metabolite of BHTOOH was detected in keratinocytes: BHT-quinol (2,6-di-tert-butyl-4-methyl-4-hydroxyl-2,5-cyclohexadienone), while incubation of BHTOOH with hematin produced several metabolites: oxacyclopentenone (2,5-di-tert-butyl-5-(2'-oxopropyl)-4-oxa-2-cyclopentenone), BHT-quinone (2,6-di-tert-butyl-p-benzoquinone), BHT, BHT-stilbenequinone (3,5,3',5'-tetra-tert-butylstilbene-4,4'-quinone), and BHT-quinone methide (2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone). Thus, radical as well as non-radical reactive intermediates can be formed during metabolism of BHTOOH. Several of the stable metabolites of BHTOOH were evaluated for possible promoter activity in a short-term bioassay, induction of ornithine decarboxylase (ODC) activity in mouse skin. In contrast to the action of BHTOOH, topical application of equimolar doses of BHT-quinol, BHT-quinone, BHT-stilbenequinone, as well as BHT itself, did not induce epidermal ODC activity. Thus, reactive metabolites of BHTOOH such as the BHT-phenoxyl radical or BHT-quinone methide may be involved in the molecular mechanisms of action of this hydroperoxide tumor promoter.
BHTOOH(2,6 - 二叔丁基 - 4 - 氢过氧基 - 4 - 甲基 - 2,5 - 环己二烯酮)是食品抗氧化剂BHT(2,6 - 二叔丁基 - 4 - 甲基苯酚)的一种代谢产物,此前已被证明在小鼠皮肤中起肿瘤促进剂的作用。对BHTOOH的代谢进行了研究,以评估活性中间体在介导该组织肿瘤促进作用中的作用。使用电子顺磁共振(EPR)光谱在分离的新生小鼠角质形成细胞或无细胞血红素系统中对BHTOOH的自由基代谢产物进行了表征,而使用HPLC分离结合紫外或质谱检测对非自由基、EPR沉默产物进行了表征。将BHTOOH与角质形成细胞或血红素一起孵育会导致产生可通过EPR光谱检测到的BHT - 苯氧自由基。在暴露于BHTOOH之前通过热灭活细胞可防止BHT - 苯氧自由基的形成。在角质形成细胞中仅检测到一种BHTOOH的非自由基代谢产物:BHT - 氢醌(2,6 - 二叔丁基 - 4 - 甲基 - 4 - 羟基 - 2,5 - 环己二烯酮),而将BHTOOH与血红素一起孵育则产生了几种代谢产物:氧杂环戊烯酮(2,5 - 二叔丁基 - 5 - (2'-氧代丙基) - 4 - 氧杂 - 2 - 环戊烯酮)、BHT - 醌(2,6 - 二叔丁基 - 对苯醌)、BHT、BHT - 芪醌(3,5,3',5'-四 - 叔丁基芪 - 4,4'-醌)和BHT - 醌甲基化物(2,6 - 二叔丁基 - 4 - 亚甲基 - 2,5 - 环己二烯酮)。因此,在BHTOOH的代谢过程中可以形成自由基以及非自由基活性中间体。在一项短期生物测定中,对BHTOOH的几种稳定代谢产物的可能促进活性进行了评估,即诱导小鼠皮肤中的鸟氨酸脱羧酶(ODC)活性。与BHTOOH的作用相反,局部应用等摩尔剂量的BHT - 氢醌、BHT - 醌、BHT - 芪醌以及BHT本身均未诱导表皮ODC活性。因此,BHTOOH的活性代谢产物,如BHT - 苯氧自由基或BHT - 醌甲基化物,可能参与了这种氢过氧化物肿瘤促进剂的分子作用机制。